HEALTH● LOWJun 26 · Jun 26, 2026, 12:22 PM
Replimune to face AdCom panel as lead drug accepted for FDA review
Seeking Alpha Tech
Replimune's lead drug has been accepted for FDA review and is slated to face an AdCom panel.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH45m agoColorectal cancer rates surge across all adults as scientists fear invisible environmental threatThe Independent WorldHEALTH1h ago154 Katsina students discharged after hospitalisation, cause remains unclearPremium TimesHEALTH1h agoHow to do more physical exercise without it seeming like itBBC AfriqueHEALTH1h agoNigeria’s under-five mortality rate drops 17%, neonatal deaths rise – OfficialPremium Times